产品名称：Human IRTA2 Antibody (Cevostamab, Research Use)
产品编号：NBR-0427
针对靶点：IRTA2
抗体药商品名：Cevostamab
抗体药描述：Cevostamab (BFCR4350A), a bispecific antibody developed by Roche, induces durable and deep responses in heavily pre-treated patients with relapsed or refractory multiple myeloma, according to early data from a Phase 1 trial. 产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

  Gene Name: IRTA2
Synonyms: BXMAS1; CD307e; FCRH5; IRTA2
Target Description: May be involved in B-cell development and differentiation in peripheral lymphoid organs and may be useful markers of B-cell stages. May have an immunoregulatory role in marginal zone B-cells.
Ensembl: ENSG00000143297
Uniprot: Q96RD9